Filings

6 documents · 28 matches

1. GDRX GoodRx Holdings, Inc. 10-Q 2026-08-05

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   relief from the potential imposition of a 100% tariff on any branded or patented pharmaceutical product produced outside of
   2 matches in this document Show context Copy citation

2. GDRX GoodRx Holdings, Inc. 10-Q 2026-05-06

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   relief from the potential imposition of a 100% tariff on any branded or patented pharmaceutical product produced outside of
   2 matches in this document Show context Copy citation

3. GDRX GoodRx Holdings, Inc. 10-K 2026-02-26

   Item 1A. Risk Factors.

   actions, tariffs, competitive pressures, or otherwise, that reduce or adversely impact fees generated by PBMs or directly by
   8 matches in this document Show context Copy citation

4. GDRX GoodRx Holdings, Inc. 10-Q 2025-11-04

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   potential imposition of a 100% tariff on any branded or patented pharmaceutical product produced outside of the United
   8 matches in this document Show context Copy citation

5. GDRX GoodRx Holdings, Inc. 10-Q 2025-08-06

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   new or increased tariffs and socio-political events, has resulted in, and may continue to result in, significant disruption of
   4 matches in this document Show context Copy citation

6. GDRX GoodRx Holdings, Inc. 10-Q 2025-05-07

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   new or increased tariffs and socio-political events, has resulted in, and may continue to result in, significant disruption of
   4 matches in this document Show context Copy citation